A Kher

1.2k citations

42 papers · 859 indexed · h-index 15

Impact in

Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 5%
- Atrial Fibrillation Management and Outcomes
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases

Papers in ⓘ

Internal Medicine 31
- Venous Thromboembolism Diagnosis and Management 31
Cardiology and Cardiovascular Medicine 20
- Atrial Fibrillation Management and Outcomes 11
- Acute Myocardial Infarction Research 5
- Antiplatelet Therapy and Cardiovascular Diseases 3

Co-authors: M Samama (5 shared papers)Jean‐Noël Fiessinger (3 shared papers)L. Bara (2 shared papers)Eliane M. Billaud (1 shared paper)Martine Alhenc‐Gelas (2 shared papers)J.F. Vitoux (2 shared papers)Carl Olsson (1 shared paper)Karin Söderberg (1 shared paper)
Journals: Thrombosis and Haemostasis (5 papers)Thrombosis Research (4 papers)International Journal of Clinical Practice (2 papers)European Journal of Clinical Pharmacology (2 papers)British Journal of Anaesthesia (1 paper)
Partner nations: France United States Switzerland

In The Last Decade

A Kher

39 papers receiving 771 citations

Peers

Countries citing papers authored by A Kher

Since Specialization

Citations

This map shows the geographic impact of A Kher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Kher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Kher more than expected).

Fields of papers citing papers by A Kher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Kher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Kher. The network helps show where A Kher may publish in the future.

Co-authors

The 25 scholars most cited alongside A Kher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Kher Line = papers co-authored together A Kher links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration Thrombosis Research ·L. Bara, Eliane M. Billaud, G. Gramond, A Kher, M Samama	1985	147
2	Once-daily Subcutaneous Dalteparin, a Low Molecular Weight Heparin, for the Initial Treatment of Acute Deep Vein Thrombosis Thrombosis and Haemostasis ·Jean‐Noël Fiessinger, María Fernanda López Fernández, E. Gatterer, S. Granqvist, A Kher, Carl Olsson, Karin Söderberg	1996	118
3	Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group. PubMed ·Martine Alhenc‐Gelas, C Jestin-Le Guernic, J.F. Vitoux, A Kher, M Aïach, Jean‐Noël Fiessinger	1994	86
4	Adjusted Versus Fixed Doses of the Low-Molecular-Weight Heparin Fragmin in the Treatment of Deep Vein Thrombosis Thrombosis and Haemostasis ·Martine Alhenc‐Gelas, C. Jestin-Le Guernic, J.F. Vitoux, A Kher, Martine Aiach, Jean‐Noël Fiessinger, (unknown)	1994	74
5	Randomized Trial of a Low-Molecular-Weight Heparin (Kabi 2165) versus Adjusted-Dose Subcutaneous Standard Heparin in the Prophylaxis of Deep-Vein Thrombosis after Elective Hip Surgery Pathophysiology of Haemostasis and Thrombosis ·M Dechavanne, D Ville, M. Berruyer, Frédérique Trepo, F. Daléry, N Clermont, J.-L. Lerat, B. Moyen, Lukáš Fischer, A Kher, P Barbier	1989	72
6	Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin®) in the prophylaxis of thromboembolic complications of abdominal oncological surgery European Journal of Clinical Investigation ·Fricker Jp, Y Vergnes, R. SCHACH, A. Heitz, Michael Eber, L. Grunebaum, M-L Wiesel, A Kher, P Barbier, Jean‐Pierre Cazenave	1988	72
7	Controlled Trial of Platelet Anti-Aggregating Agents and Subcutaneous Heparin in Prevention of Postoperative Deep Vein Thrombosis in High Risk Patients Pathophysiology of Haemostasis and Thrombosis ·M Dechavanne, D Ville, J J Viala, A Kher, Jacques Faivre, M.B. Pousset, H Dejour	1975	27
8	Kinetic Inductance Parametric Up-Converter Journal of Low Temperature Physics ·A Kher, Peter K. Day, Byeong Ho Eom, J. Žmuidzinas, H. G. LeDuc	2015	21
9	Emergency care of patients receiving non-vitamin K antagonist oral anticoagulants British Journal of Anaesthesia ·John W. Eikelboom, S. Kozek-Langenecker, A. Exadaktylos, Angelika Bátorová, Z Boda, F. Christory, Ivan Gornik, Gintautas Kėkštas, A Kher, Radko Komadina, Olena Koval, Gorana Mitić, T Novikova, E. Pazvanska, Svetlana Ratobilska, J. Sütt, Asher Winder, D. A. Zateyshchikov	2017	20
10	Primary and secondary prophylaxis of venous thromboembolism with low-molecular-weight heparins: prolonged thromboprophylaxis, an alternative to vitamin K antagonists Journal of Thrombosis and Haemostasis ·A Kher, M Samama	2005	19
11	Pharmacokinetics of a low molecular weight heparin [Fragmin®] in young and elderly subjects Thrombosis Research ·Guy G. Simoneau, Jean‐François Bergmann, A Kher, Claudine Soria, G Tobelem	1992	18
12	Three-dimensional composite metallodielectric nanostructure for enhanced surface plasmon resonance sensing Applied Physics Letters ·Haiping Matthew Chen, Xin Lin, A Kher, Yeshaiahu Fainman	2009	16
13	Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation International Journal of Clinical Practice ·Kurt Huber, Stuart J. Connolly, A Kher, F. Christory, Gheorghe‐Andrei Dan, Róbert Hatala, Róbert Gábor Kiss, Bernhard Meier, Béla Merkely, Burkert Pieske, Tatjana Potpara, Janina Stępińska, N. Vene Klun, Dragoş Vinereanu, Petr Widimský	2013	15
14	[Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study]. PubMed ·Martine Aiach, Fiessinger Jn, Vitoux Jf, A Derlon, Gilles Grollier, Le Querrec A, M Gouault-Heilmann, Y. Huet, A. Franco, Benoı̂t Polack, P Pouzol, A. Dubois, Jean‐François Schved, B Boneu, J Guittard, Piérre Siè, Heilmann Jj, A Kher, I Haye	1989	15
15	Long-term anticoagulant therapy in patients with coronary artery disease European Heart Journal ·Steen Husted, Birgitte Klindt Ziegler, A Kher	2006	14
16	[Follow-up of the treatment by direct thrombin inhibitors: activated partial thromboplastin time or ecarin clotting time]. PubMed ·A Kher, Isabelle Gouin, M Samama	2000	14
17	Marked potentiation of the plasminogenolytic activitiy of pro-urokinase by unfractionated heparin and a low molecular-weight heparin Thrombosis Research ·A.M. Dosne, A.V. Bendetowicz, A Kher, M Samama	1988	13
18	Effect of Standard Heparin and a Low Molecular Weight Heparin on Thrombolytic and Fibrinolytic Activity of Single-Chain Urokinase Plasminogen Activator In Vitro Thrombosis and Haemostasis ·Dayse Maria Lourenço, A.M. Dosne, A Kher, M Samama	1989	12
19	Spontaneous Platelet Aggregation in Heparin-Treated Patients Acta Haematologica ·C Lecrubier, J Conard, M.H. Horellou, A Kher, M Samama	1984	12
20	Venous thromboembolism in the medically ill patient: a call to action International Journal of Clinical Practice ·Jean‐François Bergmann, A Kher	2005	10

About A Kher

A Kher is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine, Hematology, Emergency Medical Services and Surgery, having authored 42 papers that have together received 859 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (31 papers), Atrial Fibrillation Management and Outcomes (11 papers), Heparin-Induced Thrombocytopenia and Thrombosis (10 papers), Blood Coagulation and Thrombosis Mechanisms (8 papers), Acute Myocardial Infarction Research (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Central Venous Catheters and Hemodialysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). The work is most often cited by research in Internal Medicine (665 citations), Cardiology and Cardiovascular Medicine (575 citations), Hematology (182 citations), Emergency Medical Services (72 citations) and Surgery (360 citations). A Kher has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include M Samama, Jean‐Noël Fiessinger, L. Bara, Eliane M. Billaud, Martine Alhenc‐Gelas, J.F. Vitoux, Carl Olsson, Karin Söderberg, María Fernanda López Fernández and S. Granqvist. Their work appears in journals such as Thrombosis and Haemostasis, Thrombosis Research, International Journal of Clinical Practice, European Journal of Clinical Pharmacology and British Journal of Anaesthesia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact